|
Delayed
Nasdaq
|
5-day change | 1st Jan Change | ||
| - USD | -.--% |
|
-.--% | - |
| 21-01-19 | Integra LifeSciences Holdings Corporation completed the acquisition of ACell, Inc for approximately $410 million. | CI |
| 20-12-22 | ACell, Inc. Announces CE Mark Approval | CI |
| Manager | Title | Age | Since |
|---|---|---|---|
Matthew R. Kunst
DFI | Director of Finance/CFO | - | 2019-12-31 |
Patty Meehan
ADM | Chief Administrative Officer | - | 2001-12-31 |
Jim Kuras
CTO | Chief Tech/Sci/R&D Officer | - | 2019-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Kyle C. Kerbawy
CHM | Chairman | 79 | 2015-07-31 |
Sally L. Maher
BRD | Director/Board Member | - | 2019-04-30 |
| Director/Board Member | 71 | 2019-06-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 340M | |
| -0.03% | -2.64% | -24.16% | +4.23% | 175B | |
| -2.69% | -4.05% | -7.32% | +11.14% | 111B | |
| +1.25% | -2.17% | -0.15% | +70.92% | 58.7B | |
| +1.53% | +1.90% | +15.16% | +55.54% | 49.27B | |
| -1.01% | -0.56% | -1.10% | -29.61% | 49.57B | |
| -0.05% | -3.23% | +30.36% | -7.14% | 32.69B | |
| -0.26% | +1.60% | - | - | 30.69B | |
| +0.26% | +1.49% | +44.68% | +0.38% | 26.51B | |
| +1.20% | +6.91% | +27.75% | -2.05% | 23.95B | |
| Average | +0.52% | +0.08% | +10.65% | +12.93% | 55.78B | |
| Weighted average by Cap. | +0.68% | -1.37% | -2.87% | +13.55% |
| 2018 | 2019 | |
|---|---|---|
| Net sales | 89.22M 78.74M 74.5M 67.56M 127M 8.56B 128M 894M 344M 4.37B 335M 328M 14.07B | 101M 88.95M 84.16M 76.33M 143M 9.67B 145M 1.01B 389M 4.94B 378M 370M 15.89B |
| Net income | -3.13M -2.76M -2.61M -2.37M -4.45M -300M -4.49M -31.37M -12.09M -153M -11.76M -11.5M -494M | 1.45M 1.28M 1.21M 1.1M 2.06M 139M 2.08M 14.51M 5.59M 70.99M 5.44M 5.32M 228M |
| Net Debt | - | - |
Employees
-
- Stock Market
- Stocks
- ACLL Stock
Select your edition
All financial news and data tailored to specific country editions
